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ABSTRACT 
 
Diet and physical activity play key roles in maintaining health and preventing or delaying 
disease. The global prevalence of dementia, an umbrella term describing a set of symptoms 
which affect cognitive function, is set to rise dramatically by 2050, with current drug treatments 
inadequate. Diet and physical activity are modifiable factors in dementia, influencing both 
disease risk and pathophysiology. It has been known since the 1950s that a Mediterranean diet 
has positive health benefits. Over the past 25 years, a causal link has been shown between 
consumption of a Mediterranean diet and decreased risk of cardiovascular disease (CVD), 
particularly in Mediterranean countries. There have also been indications that a Mediterranean 
diet and increased physical activity can improve cognitive health and delay the onset of 
dementia. However, causative demonstrations of these effects, as well as the feasibility of 
implementing such lifestyle changes in a non-Mediterranean population, are lacking. The 
MedEx-UK (Diet, physical activity and dementia risk in UK adults) programme will attempt to 
address both these points.  
 
Introduction 
The World Health Organisation (WHO) defines dementia as a syndrome, usually progressive, where 
there is deterioration in cognitive function beyond what might be expected from normal ageing (WHO 
2018). There are many dementia subtypes, with Alzheimer’s disease and vascular dementia 
accounting for up to 80% of cases, and prevalence is rapidly increasing in the UK and worldwide 
(SACN 2018). Globally, around 50 million people currently have dementia, with nearly 10 million 
new cases every year, and there is a predicted tripling in prevalence to over 150 million by 2050 
(WHO 2018). In the UK, the Alzheimer’s Society note that 816,000 people were affected by dementia 
in the UK in 2014 (AS 2014), and two years later, it had overtaken ischemic heart disease to become 
the leading cause of death in England and Wales, accounting for 12% of registered deaths (ONS 
2017).  The associated social and financial implications are huge, the latter suggested as $2 trillion 
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globally by 2030 (WHO 2018).  Some authors have suggested that dementia represents the greatest 
global challenge for health and social care in the 21st century (Livingston et al. 2017). 
 
Encouragingly, age-specific incidence in dementia is declining, certainly in the UK, US and Sweden 
(Mathews et al. 2013), which may in part be attributable to improved cardiovascular health (Wu et al. 
2016). Many of the key biological processes underlying the disease are potentially modifiable by 
behavioural intervention, such as with diet and physical activity (Deckers et al. 2015). A recent report 
noted that delaying the onset of dementia by 2 or 5 years would result in a 19% and 33% reduction in 
prevalence respectively by 2050, and a much lower prevalence of severe dementia (Lewis et al. 
2014). In the absence of a cure or effective drug intervention, and with some pharmaceutical 
companies unwilling to invest more money in this area, investigating the potential of modifiable 
factors such as diet and physical activity to delay progression of dementia is an urgent concern.  Two 
recent reviews provide focus for future work. First, the UK Scientific Advisory Committee on 
Nutrition (SACN) statement entitled 'Diet, Cognitive Impairment and Dementias' (2018) concluded 
there is evidence of the specific benefits of a Mediterranean dietary pattern (MDP) on reducing the 
risk of dementia, although noted thatmore evidence is needed  from randomised control trials (RCTs). 
Second, a recent Lancet Commission stated that of three mechanisms linked to dementia, adherence to 
a Mediterranean diet could positively influence two (‘reduced brain inflammation’ and ‘reduced brain 
damage’), and physical activity could positively affect all three (the third being ‘increased brain 
cognitive reserve’) (Livingston et al. 2017).The MedEx-UK programme will specifically study the 
effects of a Mediterranean diet and physical activity on cognitive function in UK adults at above 
average risk of dementia. 
 
The Mediterranean diet pattern and health 
The benefits of what Ancel Keys described as a ‘good Mediterranean diet’ on serum cholesterol levels 
were first observed by him and his co-workers in Italy in the 1950s, and led to the subsequent 
publication of the seven countries study (Keys et al. 1995). Epidemiological evidence from large 
cohorts demonstrates protective effects of the Mediterranean diet against cardiovascular diseases 
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(CVD), hypertension, obesity, cancer and all-cause mortality. Subsequently, RCTs have demonstrated 
benefits of the MDP for the primary and secondary prevention of CVD, type 2 diabetes, atrial 
fibrillation and breast cancer (Tosti et al. 2017).  
 
The Mediterranean diet is defined as being rich in plant foods (cereals, fruit, vegetables, legumes, tree 
nuts, seeds and olives), with olive oil as the principal source of added fat. Also important are 
moderate to high intakes of fish and seafood with a correspondingly lower consumption of red meat, 
moderate consumption of eggs, poultry and dairy products, and a moderate intake of alcohol (mainly 
wine during meals). In addition, and sometimes forgotten, are considerations such as a preference for 
seasonality, fresh and minimally processed foods, conviviality (e.g. eating meals slowly in the 
company of others), as well as a lifestyle promoting regular physical activity and adequate rest (Bach-
Faig et al. 2011).  
 
In a recent review on the health benefits of the MDP, Tosti and colleagues (2017) suggested that the 
most important health-promoting mechanisms induced by a MDP are: a lipid-lowering effect; 
protection against oxidative stress, inflammation and platelet aggregation; modification of hormones 
and growth factors involved in cancer; the inhibition of nutrient sensing pathways by restricting 
specific amino acids; and gut microbiota-mediated production of metabolites. In addition, Shannon 
and colleagues (2018) also note the potential of a MDP to increase nitric oxide (NO) production, 
implicated in many complementary physiological processes such as blood pressure regulation, 
glucose homeostasis, and neurotransmission. Paradoxically, many of the good habits of the traditional 
Mediterranean diet and way of life first described by Keys in the 1950s are being lost in countries 
where they were first observed (e.g. Italy, Spain, Greece) with a corresponding increase in metabolic 
diseases such as CVDs and certain cancers (Tosti et al. 2017). 
 
 
Heart health and cognitive health 
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The effect of a MDP on CVD risk was initially of great interest to Keys and other researchers, in light 
of the historical high rate of CVD observed in the US and Northern Europe compared to the 
Mediterranean countries. The Lyon Diet Heart study of the 1990s was the first RCT to show a 
protective effect of a MDP against CVD mortality in 605 patients who had previously suffered 
myocardial infarction (MI). So successful was the trial, it was stopped early after the intervention 
group showed a massive 73% reduction in the rate of cardiac deaths and non-fatal MIs combined  
compared to controls after 27 months (de Lorgeril et al. 1994). Subsequently, the multi-centre 
Prevención con Dieta Mediterránea (PREDIMED) study, a large randomised intervention of the 
effects of the Mediterranean diet supplemented with key ingredients, was published by a Spanish 
consortium of researchers (Estruch et al., 2013). Participants (n=7447) aged 55 to 80 years and at high 
risk of CVD were randomised into one of three study groups: Mediterranean diet supplemented with 
extra-virgin olive oil (EVOO, 1 litre per week); Mediterranean diet supplemented with nuts (30 g per 
day of mixed tree nuts); or a control group (given advice to reduce dietary fat based on American 
Heart Association recommendations).  An approximate 30% reduction in the relative risk of major CV 
events was observed in both intervention groups compared with controls after a median 4.8 year 
follow-up [adjusted hazard ratios (HR) 0.70 (95% CI: 0.54 to 0.92) and 0.72 (95% CI: 0.54 to 0.96) 
for the EVOO and nuts groups respectively]. 
 
Such powerful effects of the Mediterranean diet on  CVD outcomes have been followed by evidence 
on the potential of a Mediterranean diet to improve cognitive health, and delay or reduce the incidence 
of dementia. As mentioned previously, CVD and dementia share some underlying physiological 
processes, such as deregulated glucose and lipid metabolism, reduced vascular function and tissue 
perfusion, and a pro-inflammatory and oxidative state. It is interesting to note that in the PREDIMED 
study, stroke risk (a component of the primary outcome score) decreased significantly by almost 40% 
in both intervention groups combined. It is therefore likely that improved cardiovascular health, 
including increased cerebral blood flow, contribute to the improved cognition associated with a MDP.  
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SACN has recently reviewed the epidemiological evidence from a number of meta-analyses and 
systematic reviews of the effects of a MDP on cognitive function and dementia (including a total of 
19 prospective cohort studies in participants ranging from 62- to 80-years-old) and note that the 
majority of these studies show a beneficial association (SACN 2018). For example, a meta-analysis 
by Singh and colleagues (2014) noted that subjects with the greatest adherence to a MDP (highest 
versus lowest tertile) had a 27% reduced risk of developing mild cognitive impairment (MCI) [two 
prospective cohort studies (PCS): HR 0.73 (95% CI: 0.56 to 0.96)], a 36% reduced risk of developing 
Alzheimer’s disease (AD) [two PCS: HR 0.64 (95% CI: 0.46 to 0.89)] and a 33% reduced risk of 
developing either MCI or AD [four PCS: HR 0.67(95% CI: 0.55 to 0.81)]. Cao et al. (2016) observed 
similar effects sizes, in a meta-analysis that included five PCS [3 of which were also included in 
Singh et al. (2014)] and which showed positive association between a MDP and reduced risk of 
developing cognitive impairment (MCI or dementia) [relative risk (RR) 0.69, 95% CI: 0.57 to 0.84]. 
Psaltopoulou et al. (2013) pooled data from four PCSs, four cross-sectional studies and one case-
control study in a meta-analysis which showed that high (but not moderate) adherence to a MDP was 
associated with less cognitive impairment (MCI, AD and other dementias; RR 0.60, 95% CI: 0.43 to 
0.83). Finally, Sofi et al. (2010) observed in a meta-analysis of four PCS that a two-point increase in a 
9-point Mediterranean diet adherence score (of which a higher score shows better compliance to a 
MDP) was associated with lower risk of developing neurodegenerative diseases. 
 
Of particular relevance to the planned MedEx-UK study, is a 14 year prospective cohort study 
comprising 1880 community-dwelling elders without dementia living in New York. This showed that 
both Mediterranean-type diet adherence [compared with low diet score, HR or high diet score was 
0.60 (95% CI: 0.42 to 0.87)] and physical activity [compared with no physical activity, HR for high 
physical activity was 0.67 (95% CI: 0.47 to 0.95)] were associated with lower AD risk (Scarmeas et 
al. 2009). Compared with those neither adhering to the diet nor participating in physical activity, 
volunteers with the highest adherence to a MDP  and high physical activity had a lower risk of AD 
[HR, 0.65 (95% CI: 0.44 to 0.96)]. 
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The only RCT included by SACN on the effect of a MDP on cognitive health is a sub-study of the 
original PREDIMED trial from the Navarra cohort (Martinez-Lapiscina 2013a). This showed small 
but significant benefits in both Mediterranean diet intervention groups compared with the control 
group for the Mini-mental State Examination [MMSE; HR 0.62 (95% CI: 0.18 to1.05) for the EVOO 
group and HR 0.57 (95%CI 0.11 to 1.03) for the nuts group,  of a 30 point scale] for the clock 
drawing test, a simple tool that is used to screen people for signs of neurological problems [HR 0.51 
(95% CI: 0.20 to 0.82) for the EVOO  group and HR 0.33 (95% CI: 0.003 to 0.67) for the nuts group, 
of a 7 point scale] in 522 adults over 6.5 years. Additionally, MCI was assessed in a sub-cohort of the 
same trial (n=268) and a reduced risk was observed in the Mediterranean diet group supplemented 
with EVOO [OR 0.34 (95%: CI: 0.12 to 0.97), but not in the group supplemented with nuts (Martinez-
Lapiscina 2013b). Notably, cognitive outcomes were only measured at the end of the follow-up 
period, and so differences may have been present at baseline (SACN 2018) 
 
A recent systematic review, however, identified five separate RCTs on the effects of a MDP on 
cognition, including five specific sub-studies from PREDIMED RCT (only two of which were 
reported by SACN; Radd-Vagenas et al. 2018). The authors note that only 8 of the 66 cognitive 
outcomes measured within these studies indicated that Mediterranean diet was associated with better 
cognitive performance, with effect sizes ranging from small (0.32) to large (1.66). They concluded 
that although there is inconsistent evidence for an overall significant effect of a Mediterranean diet on 
cognitive function, evidence from the five PREDIMED sub-studies (which were deemed to be the best 
designed) was strongest. In these trials, three composite cognitive scores (memory, frontal and global 
function) were found to be significantlyimproved by a MDP, with effect sizes ranging from 0.39 to 
1.29. This led the authors to suggest that additional research from well-designed RCTs is warranted.  
 
Future directions and MedEx-UK 
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While attempts have been made to disentangle the effects of specific components of the 
Mediterranean diet and their effects on health (which include mono- and poly-unsaturated fatty acids, 
such as oleic and omega-3s, soluble fibre, vitamins and minerals, and various polyphenols), 
intervention with a portfolio diet approach, such as a MDP, provides a more pragmatic approach from 
a public health perspective. SACN has concluded there is currently insufficient evidence linking 
individual nutrients (B vitamins, vitamins C and E and omega-3 fatty acids and polyphenols) with 
prevention of cognitive decline or cognitive impairment, and other authors have suggested synergistic 
and interactive effects of various nutrients found in the MDP on reducing inflammation (Tosti et al. 
2017).  
 
There has been recent interest in using multi-domain interventions as an approach to improve health 
outcomes. A recent example specific to dementia is the Finnish Geriatric Intervention Study to 
Prevent Cognitive Impairment and Disability (FINGER) trial, which assessed the effect of a diet 
based on Finnish Nutrition Recommendations, exercise, cognitive training and monitoring of vascular 
risk in at-risk elderly Finnish adults over a 2-year period, and reported an effect size of 0.13 on 
cognitive performance (Ngandu et al. 2015). Approaches which specifically support behavioural 
modification to improve adherence to diet or exercise may also improve the chances of a successful 
intervention. For example, the PREDIMED programme provided both individual (with a dietitian) 
and group support for participants approximately every 3 months, meaning between 12 and 26 
sessions of each depending on the overall study length, and this robust-design may have contributed 
in part to the success of the programme (Raad-Vagenas et al. 2018). 
 
Finally, SACN (2018) and Raad-Vagenas and colleagues (2018) have made recommendations for 
future research in the area of diet and cognition. A summary of salient points include: having more 
evidence from RCTs, targeting at-risk groups; using a parallel design to avoid potential residual 
changes in cross-over studies; characterising relevant genotypes and lifestyle factors related to 
cognition; using various tests of cognition and brain morphology; assessing biomarkers and 
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neuroimaging; baseline assessment of the Mediterranean diet; defining minimum quantities of 
recommended foods; providing culinary instructions (including cooking); controlling cohorts for 
relevant confounding factors, such as childhood cognitive ability; and using novel technologies to 
increase compliance, such as behavioural strategies. 
 
MedEx-UK , funded by Alzheimer’s Research UK (ARUK) to run initially between January 2018 and 
June 2020,  is the first multi-domain programme in the UK to study to effects of a MDP and physical 
activity on cognitive health. The first intervention phase of the programme is to run a feasibility study 
of changing diet and physical activity over a 24-week period (during 2019), with the intention to 
conduct a follow-on intervention study over a 2- to 5-year period to assess the effect of a MDP and 
physical activity on cognitive decline in 1000+ adults at above average risk of dementia.   Previous 
evidence has shown that adhering to a MDP in a non-Mediterranean country such as the UK can 
present certain difficulties, such as adapting to a new eating pattern, and a non-conducive British 
culture and climate, presenting potential barriers to long-term adherence (Middleton et al. 2015). 
Therefore, it is important to assess how effectively people's behaviour can be changed before 
upscaling the intervention.  
 
For the feasibility trial, the aim is to recruit 108 adults aged 55-74 years with a CVD risk profile (a 
QRISK3 score of 15 or above) and subjective memory impairment, who are therefore at above 
average risk of dementia. The study is multi-centre, being conducted at UEA (UK), Birmingham 
University (UK), and Newcastle University (UK), where recruitment will be through local general 
practitioners. Potential participants will be initially screened using an online questionnaire.  The main 
recruitment criteria are a Mediterranean diet score of less than nine (based on the same 14-point 
Mediterranean Diet Questionnaire employed by PREDIMED), and physical activity levels less than 
100 minutes per week, with exclusions for those who meet dementia or MCI criteria, or who have 
moderate to severe depression, or any other serious mental disorder.  Participants will be randomised 
onto one of three arms: MDP, MDP plus physical activity, and the control group. 
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MEDEx-UK will have a strong behavioural intervention component to help effect change. First, a 
comprehensive online platform called LEAP2 will be used, previously developed for the LiveWell 
study (Lara et al. 2016), which will allow participants to search for Mediterranean style recipes, plan 
and log their physical activity levels, be sent and receive online support, and shop (through a 
supermarket online delivery system) for Mediterranean style ingredients. The second component will 
be group-based interventions, consisting of group sessions, which will involve training on the online 
platform, explanation of the principles of the Mediterranean diet and physical activity requirements, 
peer support to identify and overcome barriers to adopting a Mediterranean diet, as well as providing 
ideas and support to adhere to it.  The control group will be provided with advice on healthy eating. 
They will have basic access to the online platform, but no group sessions beyond initial training. 
 
The primary outcome for this feasibility study will be the ability of participants to increase their 
Mediterranean diet score by at least 3 points and physical activity to over 150 minutes of moderate 
activity per week. Secondary outcomes include a battery of cognitive function tests and magnetic 
resonance imaging to examine functional and temporal changes in brain structure, vascular 
assessments including flow mediated dilation, various plasma biochemical markers and APOE 
genotyping. Although the feasibility study will be underpowered to examine the impact of 
intervention on many of these outcome measures, their inclusion is to inform the design of a larger 
follow-on MedEx-UK intervention trial. 
 
Conclusion 
 
MedEx-UK is a multi-domain programme that will study the effect of a MDP and physical activity on 
cognitive health, and will address many of the shortfalls of previous research, by having a robust 
study design, appropriate measures of diet and cognition, and behavioural intervention to increase 
compliance. If the feasibility trial is successful, a larger follow-up study will be undertaken, which 
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could eventually provide a structured and systematic approach to reducing dementia risk in at-risk 
adults using diet and exercise with group and peer support. As mentioned previously, a shift in the 
onset of dementia by even 2 years would have a significant effect on prevalence in the UK population 
with reduced burden on the NHS, as well as society in general.  
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